Can Fasting Ramadan in the Third Trimester in Pregnancy Affects the Fetal Growth.

August 9, 2017 updated by: AYMAN ABDELKADER MOHAMED ABDELKADER, Ain Shams Maternity Hospital

The Effect of 3rd Trimester Ramdan Fasting on Obestetric Outcome

Prospective comparative cohort study including 159 pregnant women at the third trimester recruited from the antenatal clinic at EL-Demerdash outpatient clinic, and followed up during the holy month of Ramadan (from 18th June To 16th July 2015).

The patients recorded their pattern of fasting during Ramadan then grouped into three groups A, B, C regarding fasting state A- Non fasting group B- Partially fasting group C- Totally fasting group

.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Many pregnant muslims women fast during Ramadan Since fasting during Ramadan is one of the five pillars of Islam and is a central part of Muslim culture, many women may fear a loss of connection with their communities or would feel guilty if they did not observe Ramadan. Each year, about 400 million out of 1 billion Muslims do this duty. Such tasks like eating, drinking, and smoking are forbidden from sunrise until sunset. Fasting during pregnancy has been always considered as a debatable condition.

Many women ask their obstetricians if fasting is safe for their baby or not? There have been many studies on metabolic changes and different aspects of human health during and after Ramadan .but there have been few studies on the effect of fasting on pregnancy outcome and there are also some controversies in the findings of different studies.

All mothers within the age range of 20 - 35 years and in the 3rd trimester pregnancy (starting from 28 weeks) which is going to be calculated according to the date of the last menstrual period & confirmed ultrasonically, normal healthy women with average body mass index (BMI) and Women included have no medical disorder.

Women who fulfilled the eligibility criteria were subjected an ultrasound fetal biometry every 2 weeks till delivery and assess fetal weight after delivery.

Study Type

Observational

Enrollment (Actual)

159

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Prospective comparative cohort study including 159 pregnant women at the third trimester recruited from the antenatal clinic at EL-Demerdash outpatient clinic, and followed up during the holy month of Ramadan (from 18th June To 16th July 2015).

The patients recorded their pattern of fasting during Ramadan then grouped into three groups A, B, C regarding fasting state A- Non fasting group B- Partially fasting group C- Totally fasting group

Description

Inclusion Criteria:

  • Age from 20 - 35 years.
  • Third trimester pregnancy (starting from 28 weeks) which is going to be calculated according to the date of the last menstrual period & confirmed by ultrasonography.
  • Normal healthy women with average body mass index (BMI). Normal range (18.5 to 25).
  • Women included have no medical disorder.

Exclusion Criteria:

  • History of systemic disorder.
  • Smoking narcotics or alcohol use.
  • Have previous history of fetal loss.
  • Multiple pregnancies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Totally fasting
Fasting each day from sunrise to sunset the whole month
Totally or partially fasting the holy month of ramadan for muslims
Partially fasting
means fasting from sunrise to sunset part of the month
Totally or partially fasting the holy month of ramadan for muslims
Non fasting
women who did not fast at all

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fetal growth
Time Frame: through study completion ( from 28 weeks pregnancy till delivery)
assessment of the fetal growth biometry ( estimated fetal weight) every two weeks,
through study completion ( from 28 weeks pregnancy till delivery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neonatal weight
Time Frame: at the time of delivery of each participant
measured in grams after delivery
at the time of delivery of each participant
mode of delivery
Time Frame: at the time of delivery of each participant
percentages of emergency CS due to presumed fetal compromise
at the time of delivery of each participant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 18, 2015

Primary Completion (ACTUAL)

July 17, 2015

Study Completion (ACTUAL)

July 1, 2016

Study Registration Dates

First Submitted

July 22, 2017

First Submitted That Met QC Criteria

August 9, 2017

First Posted (ACTUAL)

August 11, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 11, 2017

Last Update Submitted That Met QC Criteria

August 9, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AAMABDELKADER 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

no confidential data will be shared

IPD Sharing Time Frame

december 2019

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasting

Clinical Trials on Fasting

3
Subscribe